$ADVM Adverum Biotechnologies, Inc. Insider Trading Week 16/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. in week 16/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Sell | S | 38.62 | 16,875 | 651,665 | 436,181 | 453.1 K to 436.2 K (-3.72 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Grant | A | 0.00 | 2,000 | 0 | 453,056 | 451.1 K to 453.1 K (+0.44 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Rubio Roman G. | SVP, Translational ... | Option Exercise | A | 39.35 | 20,000 | 787,000 | 20,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Rubio Roman G. | SVP, Translational ... | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Option Exercise | A | 39.35 | 23,000 | 905,050 | 23,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Hull Hans | SVP, Business Opera ... | Grant | A | 0.00 | 8,000 | 0 | 11,320 | 3.3 K to 11.3 K (+240.96 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | A | 39.35 | 20,000 | 787,000 | 20,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 1,000 | 2,750 | 99,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.21 | 1,000 | 39,211 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 1,000 | 2,750 | 1,000 | 0 to 1,000 |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Option Exercise | A | 39.35 | 67,000 | 2,636,450 | 67,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Chalberg Thomas W. | Chief Executive Off ... | Grant | A | 0.00 | 23,000 | 0 | 308,988 | 286 K to 309 K (+8.04 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Grant | A | 0.00 | 2,000 | 0 | 597,989 | 596 K to 598 K (+0.34 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Option Exercise | A | 39.35 | 20,000 | 787,000 | 20,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Option Exercise | A | 39.35 | 25,000 | 983,750 | 25,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Bain Linda | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Apr 21 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 40.19 | 1,192 | 47,910 | 46,697 | 47.9 K to 46.7 K (-2.49 %) |
| Apr 20 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 42.04 | 200 | 8,408 | 595,989 | 596.2 K to 596 K (-0.03 %) |
| Apr 20 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 41.59 | 24,800 | 1,031,345 | 596,189 | 621 K to 596.2 K (-3.99 %) |